HeartBeam (BEAT)
(Delayed Data from NSDQ)
$2.21 USD
+0.01 (0.45%)
Updated May 3, 2024 04:00 PM ET
After-Market: $2.23 +0.02 (0.90%) 5:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
BEAT 2.21 +0.01(0.45%)
Will BEAT be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for BEAT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for BEAT
12 Health Care Stocks Moving In Friday's After-Market Session
HeartBeam Engages Public Ventures for Stock Sales, Ends Prior Agreement
HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time
HeartBeam reports positive results of its AI capabilities for detecting arrhythmias
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias